Nov 21 (Reuters) - Impax Laboratories Inc
* Impax Laboratories Inc - on Nov 21, co entered into amendment no. 1 to business combination agreement, dated October 17, 2017 with Atlas Holdings
* Impax Laboratories Inc - also entered into amendment no. 1 with K2 Merger Sub Corporation & Amneal Pharmaceuticals Llc
* Impax Laboratories Inc - in connection with closing, Holdco will be renamed Amneal Pharmaceuticals, Inc.
* Impax Laboratories - in connection with pipe transaction, amneal desires to revise capital structure of new amneal to provide for class B-1 stock Source text: (bit.ly/2zXs2Wt) Further company coverage: